This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Aspirin-Free Strategies in ACS: Is It the Drug or the Stent?

Sunday, February 21, 2021

Submitted by


Source Name: JACC: Cardiovascular Interventions


Michel Zeitouni Paul Guedeney

An editorial that may herald the decrease in aspirinization and the rise of ticagrelor monotherapy in Percutaneous stenting of coronary arteries. There might be a peripheral relevance to the group of our patients undergoing urgent surgical revascularisation after failed PCI: the balance of protecting the angioplasty versus minimising peri and postoperative heamorrhage is yet to be achieved.

Add comment

Log in or register to post comments